Immediate Impact
21 standout
Citing Papers
NF-κB in biology and targeted therapy: new insights and translational implications
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Works of Guanglei Yu being referenced
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
2023 Standout
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guanglei Yu | 153 | 15 | 28 | 123 | 73 | 30 | 266 | |
| A. E. Macbeth | 136 | 21 | 45 | 162 | 27 | 22 | 238 | |
| Sonia Sofìa Ocampo‐Garza | 95 | 10 | 53 | 149 | 41 | 31 | 311 | |
| Dmitri Wall | 190 | 16 | 32 | 188 | 60 | 26 | 293 | |
| Ryokichi Irisawa | 180 | 5 | 53 | 134 | 60 | 29 | 299 | |
| Youyu Sheng | 219 | 9 | 21 | 149 | 34 | 25 | 316 | |
| Wei Jing Loo | 17 | 2 | 40 | 154 | 67 | 25 | 293 | |
| Lena Möbus | 16 | 29 | 11 | 152 | 8 | 21 | 286 | |
| Parviz Toossi | 18 | 6 | 21 | 161 | 84 | 25 | 336 | |
| Sorina Dănescu | 24 | 2 | 29 | 44 | 127 | 33 | 229 | |
| Dimitrios Sgouros | 22 | 3 | 96 | 151 | 24 | 37 | 225 |
All Works
Login with ORCID to disown or claim papers
Loading papers...